Note : Les descriptions sont présentées dans la langue officielle dans laquelle elles ont été soumises.
CA 02314935 2000-06-15
WO 99/30681 PCT/US98/26580
COSMETIC MAKEUP COMPOSTTION
BACBGROUND OF THE INVENTION
1. Field of the Invention
This application relates to a makeup composition including a water in
silicone emulsion containing hydroxyacids, such as alpha hydroxyacids, beta
hydroxyacids and/or polyhydroxyacids. The makeup composition, when applied
topically to the skin, provides beneficial effects to the skin such as (i)
reducing the
appearance of Lines and wrinkles, (ii) protecting the skin from the harmful
effects
of the ultraviolet light from the sun, (iii) moisturizing and soothing the
skin, and
(iv) making the skin attractively colored. This application also relates to
methods
of topical treatment of the skin to effect such benefits.
2. Description of the Prior A~,r,~
Human skin is comprised of two principal components, the outer epidermis
and the underlying dermis, which is situated above the subcutaneous adipose or
fat
tissues. The epidermis consists of four distinct layers: stratum corneum,
stratum
granulosum, stratum spinosum and stratum basale; in the skin of palms and
soles
only, there is normally one additional zone called the stratum lucidum between
the
stratum corneum and the stratum granuiosum.
The stratum corneum or homy layer is comprised of numerous flattened
dead cells called coraeocytes. The granular layer, located below the stratum
corneum, contains large granules of keratinous materials. The spinous layer or
prickle cell Layer is located below the granular layer and composed of
keratinocytes. The basal cell layer, located below the spinous layer but above
the
dermis, is the only principal layer in the epidermis in which living cells
normally
. replicate DNA and divide into daughter cells.
After a basal cell divides, one of the daughter cells migrates into the
spinous layer where the cell starts to differentiate as a keratinocyte,
wherein
synthesis of keratin is initiated. As the keratinocyte continues to move
outward
and reaches the granular layer, more keratinous materials are synthesized as
CA 02314935 2000-06-15
WO 99/30681 PCT/US98/26580
keratin filaments and large granules. The keratinocyte loses its nucleus in
transit
through the granular layer and thereupon dies to become a corneocyte without
nucleus in the stratum corneum.
- Normally, the granular layer is a few cell layers in thickness, and the
stratum corneum may be 14-25 cell layers thick. Under normal conditions and in
most skin areas, a keratinocyte takes 14 days to move outward from the basal
cell
layer to the granular layer, and a corneocyte takes 14 days to reach the
outermost
layer of the stratum corneum to be shed; the total time from basal cell layer
to the
surface is approximately 28 days. The entire sequence of epidermal terminal
differentiation is called keratinization.
The dermis is comprised mainly of collagen, elastic fibers,
glycosaminoglycans and proteoglycans including hyaluronic acid, dermatan
sulfate
and chondroitin sulfate formerly kno~~rn as mucopoIysaccharides. Fibroblasts,
the
predominant cells of the derlnis, synthesize collagen, elastic fibers,
proteoglycans
and glycosaminoglycans. Collagen makes up approximately 77%, elastic fibers
account for about 2 % , and glycosaminoglycans constitute around 0.2 % of the
dry
weight of the dermis. Collagen provides the tensile strength of and elastic
fibers
give resilience to the dermis. The glycosaminoglycans binds water to form a
gelatinous mass between collagen and elastic fibers, which acts as a lubricant
and
shock absorber for the dermis during movement of the skin.
Several factors affect human skin and result cutaneous aging to form
wrinkles, sagging and loss of firmness and elasticity. These factors include
internal factors and external factors. Cutaneous aging, while having epidermal
concomitants, seems to involve primarily dermal and subcutaneous changes, and
is caused by (a) internal factors alone, as in intrinsic aging and (b)
external
factors, as in extrinsic aging. Intrinsic aging also is known as natural or
chronologic aging, and extrinsic aging often is called photoaging.
"Photodamage"
implies skin damage caused by chronic sun exposure. These terms may be
described as follows.
Intrinsic aging of skin, in sun-protected skin of the upper arm and
abdomen, is an inherent degenerative process that occurs in all humans and is
due
to declining physiologic functions and capacities. This degenerative process
may
include qualitative and quantitative skin changes and also includes diminished
or
-2-
CA 02314935 2000-06-15
WO 99/30681 PCTNS98/26580
defective synthesis of collagen and elastic fibers, and proteoglycans and
glycosaminoglycans in the dermis. Signs of intrinsic aging include progressive
thinning of skin, deepening of skin lines and fine wrinkles, lusterless skin
surface,
- and loss of skin elasticity and_ recoilability. Although intrinsic aging of
living
S . creatures is neither reversible nor preventable, modification and
improvement of
skin signs associated with such aging process can be achieved through topical
management.
Extrinsic aging of skin is a distinctive process caused by external factors
which include sunlight, radiation, air pollution, wind, cold, dampness, heat,
chemicals, smoke and cigarette smoking. Photoaging of skin may be defined as
destructive cutaneous changes caused by chronic exposure to sunlight. Signs of
photoaging on the face and back of hands include coarse and deepened wrinkles
due to changes and degeneration of collagen and elastic fibers; marked loss of
elasticity and recoilability; leathery skin surface and skin lesions with
abnormal
pigmentation and increased numbers of age spots, pigmented spots, blotches and
nodules. Histologically, the qualities and quantities of elastin and collagen
tissues
are changed. Normal elastin in tissues is replaced by abnormal elastin
characterized as solar elastosis, and the normal collagen fibers are
decreased.
Photodamage of skin, also called solar damage, may be defined as
cutaneous damage caused by chronic exposure to solar radiation and is
associated
with development of neoplastic lesions. Skin disorders caused by photodamage
include pre-malignant lesions, basal cell carcinomas, sqttamous cell
carcinomas
and malignant melanomas.
There are numerous products available today that report to ameliorate some
of the signs of cutaneous aging. For example, there are a number of sunscreen
patents related to treating aging skin. U.S. Patent No. 5,093,109 describes
the us
of titanium dioxide as a sunscreen which also contains antioxidants,
emulsifiers,
thickeners and colorants. U.S. Patent No. 5,204,105 describes the use of plant
and yeast extracts, vitamins E & C to improve elasticity, the use of silicones
to
improve firmness and the use of sunscreens to protect the skin from the sun. A
number of cosmetic compositions are known that contain titanium dioxide either
alone, or in combination with a silicone compound for various uses. See, U.S.
Patent Nos. 4,801,44.5, 4,820,508, 5,032,390 and 5,250,289.
-3-
CA 02314935 2000-06-15
WO 99/30681 PCTNS98/26580
Other known compositions containing sunscreens together with free radical
scavengers are described in, for example, U.S. Patent No. 5,093,109. These
compositions, however, generally are oil in water emulsions containing
ascorbyl
palmitate, which rapidly falls - apart in such an emulsion. U. S . Patent No.
5,560,917 describes a composition containing a sunscreen agent, a free radical
scavenger and a cosmetically acceptable pigment.
There also are numerous descriptions in the literature of the use of alpha
hydroxyacids and polyhydroxyacids for treating various skin disorders. U.S.
Patent No. 3,879,537 describes the use of topical compositions containing an
alpha hydroxyacid to alleviate the symptoms of ichthyosis. U.S. Patent No.
3,920,835 describes the use of topical compositions containing an alpha
hydroxyacid to alleviate the symptoms of acne. U.S. Patent No. 3,984,566
describes the use of topical compositions containing an alpha hydroxyacid to
improve the symptoms of dandruff.
Other document, for example, U.S. Patent Nos. 4,105,783, 4,197,316 and
4,380,549 describe the use of topical compositions containing an alpha
hydroxyacid to alleviate or improve the symptoms of dry skin. In addition,
U.S.
Patent No. 4,234,599 describes the use of topical compositions containing an
alpha hydroxyacid to alleviate the symptoms of actinic or nonactinic skin
keratoses. Moreover, U.S. Patent No. 4,363,815 describes the use of topical
compositions containing certain alpha hydroxyacids to improve skin conditions
characterized by inflammation or disturbed keratinization.
Recently issued U.S. Patent Nos. 5,385,938 and 5,389,677 describe the
use of compositions containing glycolic acid for topical treatment of skin
wrinkles.
Albert M. Kligman also described in U.S. Patent No. 4,877,805 that photoaging
or sun damaged skin includes loss of collagen fibers, abnormal changes in
elastic
fibers and deterioration of small blood vessels in the dermis of the skin. The
dermal components which make up the fibers of the dermis become smaller and
sparser with increasing age, usually in sundamaged facial skin. There is a
great
loss of collagen fibers resulting in looseness and easy stretchability of the
skin;
elastic fibers become abnormal so that the skin does not promptly snap back
after
being stretched. Kligman disclosed the use of retin-A to treat photoaged or
sundamaged skin.
-4-
CA 02314935 2000-06-15
WO 99/30681 PCT/US98/26580
These known compositions, are not always effective against the external
effects of sunlight and the internal effects caused by intrinsic aging.
SUMMARY OF THE INVENTION
There exists a need for a single cosmetic composition that is effective not
only against the external effects of sunlight but the internal effects caused
by
intrinsic aging. It is therefore an object of the present invention to provide
such
a composition. It is an additional object of the present invention to, provide
a
composition that achieves the objectives described above, and at the same time
colors the skin attractively.
In accordance with these and additional objects of the invention, there is
provided a water in silicone emulsified cosmetic makeup composition including:
1) At least one hydroxy acid selected from polyhydroxy acid, alpha
hydroxy acid, beta hydroxyacid, keto carboxylic acid and related
compounds;
2) Sunscreen agent(s);
3) Moisturizing agent(s);
4) Antioxidant(s);
5) Cosmetically acceptable pigment(s);
6) Silicone-containing compound(s); and
'n water.
In accordance with additional objects of the invention, there are provided
methods of reducing the appearance of lines and wrinkles, pmtecting the skin
from harnnfui effects of ultraviolet light, moisturizing, soothing and firming
the
skin and attractively coloring the skin comprising topically applying the
above
water in silicone emulsified cosmetic makeup composition in a cosmetically
effective amount to achieve the aforementioned effects.
In accordance with additional objects of the invention, there are provided
methods of making a water in silicone emulsified cosmetic makeup composition
by:
A) dissolving in water at least one hydroxy acid selected from
poiyhydroxy acid, alpha hydroxy acid, beta hydroxyacid, keto carboxylic acid
and
-5-
CA 02314935 2000-06-15
WO 99/30681 PCT/US98/26580
related compounds in water and neutralizing to a pIi of above 3.0 to provide
phase A;
B) providing an aqueous mixture containing at least one moisturizing
agent, heating the mixture, and adding this mixture to phase A to provide
phase
AB;
C) mixing at least one sunscreen agent, at least one antioxidant, at least
one surfactant and at least one silicone-containing compound at room
temperature,
followed by heating and homogenizing the mixture to provide phase C;
D) providing a mixture containing at least one sunscreen agent and at
least one cosmetically acceptable pigment, homogenizing the mixture to provide
phase D;
E) mixing phases C) and D) together and homogenize until uniform to
provide mixture CD;
F) slowly adding phase AB to phase CD to produce phase F;
G) adding to phase F a mixture containing parabens; and
IT) adding additional cosmetically acceptable pigments to provide the
appropriate color.
Additional objects and advantages of the invention will be set forth in part
in the description that follows, and in part will be obvious from the
description,
or may be learned by practice of the invention. The objects and the advantages
of this invention may be realized and obtained by means of the compositions
and
methods particularly pointed out in the appended claims.
DETAILED DESCRIPTION OF PREFERRED EMBODIMENT
Throughout this description, the expressions "alpha hydroxy acid, " "AI3A"
and "2-hydroxycarboxylic acid" are used synonymously and denote any known
alpha hydroxyacid useful in treating skin disorders, including those described
in,
inter alia, U.S. Patent No. 5,091,171, the disclosure of which is incorporated
herein by reference in its entirety. Throughout this description, the
expression
"polyhydroxy acid" denotes any of the known poly hydroxyacids reported as
being
useful in treating skin disorders, including poly hydroxyacids disclosed in
U.S.
Patent No. 5,091,171. Throughout this description, the expression "beta
hydroxyacid" denotes any beta hydroxyacid useful in treating skin disorders.
-6-
CA 02314935 2000-06-15
WO 99/30681 PCT/US98/26580
Throughout this description, the expression "keto carboxylic acid" denotes any
of
the known keto carboxylic acids reported as being useful in treating skin
disorders, including those disclosed in U.S. Patent No. 5,091,171. Throughout
_ this description, the expression "related compound" refers to compounds that
are
structurally and functionally similar to alpha hydroxyacids and polyhydroxy
acids
such as those related compounds disclosed in U.S. Patent No. 5,091,171.
For convenience, the alpha hydroxyacids, polyhydroxy acids and related
compounds which may be used in accordance with this invention may be
classified
into three groups, namely (1) 2-hydroxycarboxylic acids, (2) 2-ketocarboxylic
acids and esters thereof, and {3) other related compounds. The related
compounds
may include hydroxycarboxylic acids with the hydroxyl group at any position
other than position 2, for example position 3, position 4 or position 5, as
well as
cyclic hydrox~carboxylic acids (e.g., ascorbic acid and quinic acid), and also
may
include ketocarboxylic acids and esters thereof. Preferred related compounds
include 3-hydroxycarboxylic acids, and 2-ketocarboxylic acids and esters
thereof.
Group 1
The first group comprises organic carboxylic acids in which one hydroxy
group is attached to the 2 position carbon atom of the acid. The generic
structure
of such 2-hydroxycarboxylic acids may be represented as follows:
(RJ (Rb) C (OH) COOH
Where R.a and Re may be the same or different and are independently selected
from H, F, Cl, Br, alkyl, aralkyl or aryl group of saturated or unsaturated,
isomeric or non-isomeric, straight or branched chain or cyclic form, having 1
to
29 carbon atoms, and in addition R, and Rb may carry OH, CHO, COOH and
alkoxy group having 1 to 9 carbon atoms. In addition, the hydrogen atoms of Ra
and/or Rd may be substituted by a nonfunctional element selected from Cl, Br,
I,
S, F, or a radical such as a low alkyl or alkoxy group, saturated or
unsaturated,
having 1 to 9 carbon atoms. The alpha hydroxy acids of Group 1 may be present
as a free acid or lactone form, or in a salt form with an organic base or an
inorganic alkali. The alpha hydroxy acids of Group 1 may exist as
stereoisomers
as D, L, and DL forms when Ra and Re are not identical.
_7_
CA 02314935 2000-06-15
WO 99/30681 PCTNS98/265$0
Typical alkyl, aralkyl and aryl groups for Ra and R~ include methyl, ethyl,
propyl, isopropyl, butyl, penryl, octyl, decyl, dodecyl, hexadecyl, benzyl,
and
phenyl, etc. Alpha hydroxy acids of Group 1 may be further divided into
- subgroups comprising (1) alkyl hydroxycarboxylic acids, (2) aralkyl and aryl
hydroxycarboxylic acids, (3) polyhydroxy acids, and (4) hydroxy-polycarboxylic
acids. The following are representative alpha hydroxy acids in each subgroup.
(1) Alkyl Hydroxycarboxylic Acids
1. 2-Hydroxyethanoic acid (Glycolic acid, hydroxyacetic
acid)
(H) (IT) C (OH) COOH
2. 2-Hydroxypropanoic acid (Lactic acid)
(CH3) (H) C (OH) COOH
3. 2-Methyl 2-hydroxypropanoic acid (Methyllactic
acid)
(CH3) (CH3) C (OH) COON
4. 2-Hydroxybutanoic acid
(CZHs) (H) C (OH) COOH
5. 2-Hydroxypentanoic acid
(C3H,) (H) C (OH) COOH
6. 2-Hydroxyhexanoic acid
(C,Hg) (H) C (OH) COOH
7. 2-Hydroxyheptanoic acid
(CSHI,) (H) C (OH) COOH
8. 2-Hydroxyoctanoic acid
(C6H13) (H) C (OH) COOH
9. 2-Hydroxynonanoic acid
(C.,HIS) (H) C (OH) COOH
10. 2-Hydroxydecanoic acid
(C8H1,) (H) C (OH) COOH
11. 2-Hydroxyundecanoic acid
(C91it9) (H) C (OH) COOH
12. 2-Hydroxydodecanoic acid (Alpha hydroxylauric
acid)
(C,oH2,) (H) C (OH) COOH
13. 2-Hydroxytetradecanoic acid (Alpha hydroxymyristic
acid)
_g_
CA 02314935 2000-06-15
WO 99/30681 PCTNS98/26580
. (C~ZHs) (H) C (OH) COON
14. 2-Hydroxyhexadecanoic acid (Alpha hydroxypalmitic
acid)
(C14H29) (~ C (O~ COOH
- 15. 2-Hydroxyoctadecanoic_acid (Alpha hydroxystearic
acid)
(C1~33) (H) C (O~ COOH
16. 2-Hydroxyeicosanoic acid (Alpha hydroxyarachidonic
acid)
(C~$H3~) (I~ C (OH) COOH
17. 2-Hydroxytetraeicosanoic acid (Cerebronic
acid)
(c~H,s) {~ c (ox) cooH
18. 2-Hydroxytetraeicosenoic acid (Alpha hydroxynervonic
acid)
(C~H43) (H) C (OH) COOH
(2) Aralkyl And Aryl 2-Hydroxycarboxyiic Acids
1. 2-Phenyl 2-hydroxyethanoic acid (Mandelic
acid)
(C6H5) (H) C (OH) COOH
2. 2,2-biphenyl 2-hydroxyethanoic acid (Benzilic
acid)
(C6H5) (C6H5) C (OH) COOH
3. 3-Phenyl 2-hydroxypropanoic acid {Phenyllacdc
acid)
(C,~isCH~ (H) C (OH) COOH
4. 2-Phenyl 2-methyl 2-hydroxyethanoic acid
(Atrolactic acid)
(C6Fi5) (CH3) C (OH) COOH
5. 2-(4'-Hydroxyphenyl) 2-hydroxyethanoic acid
{4-Hydroxymandelic acid)
(HO-C6Ii4) (H) C (OH) COOH
6. 2-(4'-Chlorophenyl) 2-hydroxyethanoic acid
(4-Chloromandelic acid)
(Cl-C6Fi4) (H} C (OH) COOH
7. 2-(3'-Hydroxy-4'-methoxyphenyl) 2-hydroxyethanoic
acid
(3-Hydroxy-4-methoxymandelic acid)
(HO-, CH30-C6H3) (H) C (OH) COOH
-9-
CA 02314935 2000-06-15
WO 99/30681 PCTNS98/26580
8. 2-(4'-Hydroxy-3'-methoxyphenyl) 2-hydroxyethanoic acid
(4-Hydroxy-3-methoxymandelic acid)
(HO-,CH30-C~i3) (H) C (OH) COOH
9. 3-(2'-Hydroxyphenyl) 2-hydroxypropanoic acid
[3-(2'Hydroxyphenyl) lactic acid]
(HO-C6Ii,-CH2) (H) C (OH) COON
10. 3-(4'-Hydroxyghenyl) 2-hydroxypropanoic acid
[3-(4'-Hydroxyphenyl) lactic acid]
(HO-C6H,-CHI (H) C (OH) COOH
11. 2-(3',4'-Dihydroxyphenyl) 2-hydroxyethanoic acid
(3,4-Dihydroxymandelic acid)
(HO-,HO-C6H3) (H) C (OH) COOH
(3) Polyhydroxy Acids
1. 2,3-Dihydroxypropanoic acid (Glyceric acid)
(HOCH~ (H) C (OH) COON
2. 2,3,4-Trihydroxybutanoic acid (Isomers; erythronic acid, threonic acid)
(HOCH2 HOCH) (H) C (OH) COOH
3. 2,3,4,5-Tetrahydroxypentanoic acid (Isomers; ribonic acid, arabinoic acid,
xylonic acid, lyxonic acid)
(HOCH2 HOCH HOCH) (H) C (OH) COOH
4. 2,3,4,5,6-Pentahydroxyhexanoic acid (Isomers; allonic acid, altronic acid,
gluconic acid, mannoic acid, gulonic acid, idonic acid, galactonic acid,
talonic acid)
(HOCHZ HOCH HOCH HOCH) (I~ C (OH) COOH
5. 2,3,4,5,6,7-Hexahydroxyheptanoic acid (Isomers; glucoheptonic acid,
galactoheptonic acid etc.)
(HOCHZ HOCH HOCH HOCH HOCH) (H) C (OH) COOH
(4) Hydroxy-polycarboxylic Acids
1. 2-Hydroxypropane-1,3-dioic acid (Tartronic acid)
(HOOC) (H) C (OH) COON
-10-
CA 02314935 2000-06-15
WO 99/30681 PC'fNS98/26580
2. 2-Hydroxybutane-1,4-dioic acid (Malic acid)
(HOOC CHI {H) C (OH) COON
3. 2,3-Dihydroxybutane-1,4-dioic acid (Tartaric acid)
(HOOC HOCH) (H) C (OH) COOH
4. 2-Hydroxy-2-carboxypentane-1,5-dioic acid (Citric acid)
(HOOC CH~Z C (OH) COOH
5. 2,3,4,5-Tetrahydroxyhexane-1,6-dioic acid (Isomers; saccharic acid, muck
acid etc.)
HOOC (CHOH)4 COOH
15
The alpha hydroxy acids of Group 1 may be present in forms other than
the acid, such as, for example, salts or lactones. Typical iactone forms which
may be used in accordance with this invention include, for example,
gluconolactone, galactonolactone, glucuronolactone, galactumnolactone,
gulonolactone, ribonolactone, saccharic acid lactone, pantoyllactone,
glucoheptonolactone, mannonolactone, and galactoheptonolactone.
Group 2
The second group, which comprises compounds related to the alpha
hydroxyacids of Group 1, includes organic carboxylic acids in which one keto
group is attached to position 2 carbon atom of the acid. These compounds are
referred to herein as keto carboxylic acids or 2-ketoacids. The generic
structure
of such 2-ketoacids, or alpha ketoacid may be represented as follows:
(R~ CO COO (Its
wherein R~ and Rd can be the same or different and are each selected from H,
alkyl, aralkyl or aryl group of saturated or unsaturated, isomeric or non-
isomeric,
straight or branched chain or cyclic form, having 1 to 29 carbon atoms, and in
addition R~ may carry F, Cl, Br, I, OH, CHO, COOH and allcoxy group having
1 to 9 carbon atoms. In addition, the hydrogen atoms of R~ and/or Rd may be
substituted by a nonfunctional element selected from Cl, Br, I, S, F, or a
radical
such as a low alkyl or alkoxy group, saturated or unsaturated, having 1 to 9
carbon atoms. The alpha ketoacids may be present as a free acid or an ester
form, or in a salt form with an organic base or an inorganic alkali. The
typical
-11-
CA 02314935 2000-06-15
WO 99130681 PCT/US98/26580
alkyl, aralkyl and aryl groups for R.~ and Rd include methyl, ethyl, propyl, 2-
propyl, butyl, pentyl, hexyl, octyl, dodecyl, hexadecyl, benzyl and phenyl.
The ester form of the above-mentioned 2-ketoacids also is therapeutically
_ effective for alleviating the signs and, symptoms of cutaneous aging
including
intrinsic and extrinsic aging. For example, methyl 2-ketopropanoate and ethyl
2-
ketopropanoate are therapeutically very effective. While the mechanism of
action
of these 2-ketoacids is not known, it is believed that the ester form of the 2-
ketocarboxylic acid is chemically and/or biochemically very reactive, and a
free
2-ketoacid may be released in the skin after penetration through the stratum
corneum of the skin.
The representative 2-ketoacids and their esters of the second group are
listed below:
1. 2-Ketoethanoic acid (Glyoxylic acid)
(H) CO COOH
2. Methyl2-ketoethanoate
(I~ CO COOCH3
3. 2-Ketopropanoic acid (Pyruvic acid)
CH3 CO COOH
4. Methyl 2-ketopropanoate (Methyl pyruvate)
CH3 CO COOCH3
5. Ethyl 2-ketopropanoate (Ethyl pyruvate)
CH3 CO COOCZHS
6. Propyl 2-ketopropanoate (Propyl pyruvate)
CH3 CO COOC3H~
7. 2-Phenyl-2-ketoethanoic acid (Benzoylformic acid)
C6H5 CO COOH
8. Methyl 2-phenyl-2-ketoethanoate (Methyl benzoylformate)
C6H5 CO COOCH3
9. Ethyl 2-phenyl-2-ketoethanoate (Ethyl benzoylformate)
C6Hs CO COOC2H5
10. 3-Phenyl-2-ketopropanoic acid (Phenylpyruvic acid)
C6HSCHz CO COOH
11. Methyl 3-phenyl-2-ketopropanoate (Methyl phenylpyruvate)
- I2-
CA 02314935 2000-06-15
WO 99/30681 PCTNS98/26580
C6HSCH, CO COOCH3
12. Ethyl 3-phenyl-2-ketopropanoate (Ethyl phenylpyruvate)
C6HsCH2 CO COOC~Hs
- 13. 2-ketobutanoic acid
C2H5 CO COOH
14. 2-Ketopentanoic acid
C3H, CO COOH
15. 2-Ketohexanoic acid
C4Hq CO COOH
16. 2-Ketoheptanoic acid
CSHII CO COON
17. 2-Ketooctanoic acid
C6H,3 CO COOH
18. 2-Ketododecanoic acid
C,oH21 CO COOH
19. Methyl2-ketooctanoate
C6H14 CO COOCH3
Group 3
The third group, which also comprises related compounds, includes, inter
alia, hydroxycarboxylic acids where the hydroxy is at a position other than
position 2, and cyclic hydroxycarboxylic acids which are useful for topical
application to improve signs of aging skin and the cutaneous appendages. The
members of this group, which are more conveniently identified by name than by
generic structures, include ascorbic acid, quinic acid, isocitric acid, tropic
acid (2-
phenyl 3-hydroxypropanoic acid), trethocanic acid, 3-chlorolactic acid,
citramalic
acid, agaricic acid, aleuritic acid, pantoic acid, lactobionic acid and
hexulosonic
acid.
Group 4
The fourth group includes beta hydroxyacids in which a hydroxy group is
attached to the beta carbon atom of the acid. The generic structure of such
beta
hydroxyacids may be represented as follows:
-13-
CA 02314935 2000-06-15
WO 99130681 PCTNS98126580
R~(CR,OH)m(CH,)COOH
where R~, Rf are selected from the group consisting of hydrogen, alkyl,
aralkyl
- and aryl, where said alkyl, _aralkyl or aryl can be saturated or
unsaturated,
straight, branched or cyclic, and have from 1-25 carbon atoms. In addition,
the
hydrogen atoms of It~ and/or Rf may be substituted by a nonfunctional element
selected from Cl, Br, I, S, F, or a radical such as a low alkyl or alkoxy
group,
saturated or unsaturated, having 1 to 9 carbon atoms. In the generic structure
above, m preferably is an integer of from i to 9. The beta hydroxyacids may be
present as a free acid or an ester form, or in a salt form with an organic
base or
an inorganic alkali. Preferably, R.~ and Rf are selected from methyl, ethyl,
propyl,
2-propyl, butyl, pentyl, hexyl, octyl, dodecyl, hexadecyl, benzyl and phenyl.
The alpha hydroxyacids, polyhyrdoxyacids, 2-ketoacids, beta hydroxyacids
and related compounds are used in a cosmetically effective amount to reduce or
alleviate the signs of fine lines and wrinkles. Preferably, these compounds
are
used in an additive amount within the range of from about 0.1 to about 25 % by
weight, based on the total weight of the composition. "Additive amount, " as
it is
used herein denotes the total amount of component used in the composition,
such
as the total amount of alpha hydroxyacids, polyhydroxyacids, 2-ketoacids and
related compounds used. More preferably, these compounds are used in an
amount within the range of from about 2 to about 10 % by weight and more
preferably, from about 4 to about 8 % by weight.
Preferably, the alpha hydroxyacids, polyhydroxyacids, 2-ketoacids and
related compounds are neutralized with an appropriate base to a pH of more
than
about 3, more preferably more than about 3.5 and most preferably, to a pH of
about 3.8. Any cosmetically acceptable base can be used to neutralize the
alpha
hydroxyacids, polyhydroxyacids, 2-ketoacids and related compounds. Preferably,
the base is selected from sodium hydroxide or ammonium hydroxide or
triethanoloamine and most preferably, the base is ammonium hydroxide. Those
skilled in the art are capable of determining an effective amount of alpha
hydroxyacids, polyhydroxyacids, 2-ketoacids and related compound together with
an acceptable quantity of base using the guidelines provided herein.
-14-
CA 02314935 2000-06-15
WO 99/30681 PCT/US98/26580
Throughout this description, the expression "sunscreen agent" denotes
known sunscreen agents that are useful in absorbing, screening or preventing
ultraviolet rays from penetrating the skin. Preferably, the sunscreen agent is
titanium dioxide or zinc oxide, and more preferably the sunscreen agent is
coated
with a polymeric material or other cosmetically acceptable coating. Preferred
sunscreen agents can be selected from microfine titanium dioxide coated with
aluminum hydroxide and stearic acid (aluminum stearate), cosmetic grade
titanium
dioxide coated with C9-C 15 polyfluoroalkyl phosphate, polymer coated zinc
oxide, octyi dimethyl PABA, PABA and its esters, benzophenone-3, octyl
salicylate, menthyl anthranilate, and phenylbenzimidazole sulfonic acid.
The sunscreen agent can be used in any effective amount that will prevent
or inhibit ultraviolet rays from penetrating the skin. Specifically, the
sunscreen
agent is provided in an amount to provide a sunscreen protection factor of at
least
8, more preferably, at least 15, and even more preferably, at least 30.
Preferably, the sunscreen agent is used in an amount within the range of from
about .1 % to about 50 % by weight, based on the total weight of the
composition.
More preferably, the sunscreen agent is used in an additive amount within the
range of from about 0.1 to about 20 % by weight, and most preferably, within
the
range of from about 6 to about 16 % by weight.
Throughout this description, the expression "moisturizing agent(s)" denotes
any agents that provide a moisturizing effect to the skin, e.g., any known
humectant. Any moisturizing agent can be used in any moisturizing effective
amount. Preferably, the moisturizing agent is selected from glycerin, butylene
glycol or their derivatives such as 1,3-butylene glycol and glycerine,
propylene
glycol, sorbitol, sodium PCA, glucam E-10, glucam E-20, and POE (7-26)
glycerine. Those skilled in the art recognize useful moisturizing agents that
can
be used in the present invention, using the guidelines provided herein.
Preferably,
the moisturizing agent is used in an amount within the range of from about 0.1
to
about 10% by weight, based on the total weight of the composition, more
preferably, from about 0.1 to about 5 % by weight, and most preferably, from
about 1 to about 5 % by weight.
Any antioxidants) can be used in any effective amount to prepare the
cosmetic composition of the invention. Preferably, the antioxidant is a
natural
-15-
CA 02314935 2000-06-15
WO 99/30681 PCT/US98/26580
antioxidant such as a Vitamin E derivative, e. g. , Vitamin E linoleate,
Vitamin E,
Vitamin E POE succinate, Vitamin E acetate, ascorbic acid, ascorbyl palmitate
and ascorbyl-PMG. The antioxidant useful in the invention can be used in an
- additive amount within the range of from about 0.1 to about 10% by weight,
based on the total weight of the composition, preferably, from about 0.1 to
about
5 % by weight, and more preferably, from about 0.5 to about 1 % by weight.
Throughout this description, the expression "cosmetically acceptable
pigment" denotes any pigments that are useful in providing color to a cosmetic
composition, and which do not adversely affect the skin. Any cosmetically
acceptable pigment can be used in any effective amount to prepare the cosmetic
composition of the invention. Preferably, the cosmetically acceptable pigment
is
an inorganic pigment such as iron oxide (yellow, red and black), manganese
oxide, and F D & C Aluminum Lakes. Zinc oxide and titanium dioxide, although
described herein as being useful sunscreen agents, can also be used within the
context of the present invention as a pigment. The pigments, although useable
in
raw form as an iron oxide, preferably are coated with a polymeric coating,
more
preferably, the pigments are polyfluoroalkyl coated inorganic pigments. The
pigments useful in the invention can be used in an additive amount within the
range of from about 0. I to about 25 % by weight, based on the total weight of
the
composition, preferably, from about I to about 20% by weight, and more
preferably, from about 2 to about 15 % by weight.
The water in silicone emulsified cosmetic makeup composition of the
present invention also includes silicone-containing compounds. Any known
cosmetically silicone-containing compound can be used in a cosmetically
effective
amount. Preferably, the silicone-containing compounds) is selected from
cyclomethicone, dimethicone and derivatives thereof, such as cyclomethicone/
quaternium-18 hectorite, cyclomethicone polyol, dimethicone polyol, and cetyl
dimethicone copolyol and combinations thereof. Those skilled in the art will
appreciate that the silicone-containing compounds) also can function as an
emulsifier, especially when the silicone-containing compound is selected from
dimethicone polyol or cetyl dimethicone copolyol. Silica also is preferably
used
in the present invention. More preferably, the silicone-containing compounds
are
- 16-
CA 02314935 2000-06-15
WO 99/30681 PCT/US98/26580
selected from cyclomethicone, dimethicone, phenyl methicone, phenyl
dimethicone
and phenyl trimethicone.
The silicone-containing compounds preferably are used in an amount
- within the range of from about 1 to about 50 % by weight, based on the total
weight of the composition. More preferably, the silicone-containing compounds
are used in an additive amount within the range of from about 5 to about 30%
by
weight, and most preferably, from about 10 to about 25 % by weight.
The balance of the composition is comprised of customary additives
selected from auxiliaries, filler, emulsifiers, surfactants, solvents,
buffers,
IO emollients and other cosmetically acceptable carriers and fillers, and
water. Other
conventional additives can be used in the present invention, including
antioxidants,
dispersants, humectants, thickeners and preservatives. Water typically is
deionized water, and the amount of water typically is anywhere from about 10
tc
about 80 by weight, based on the total weight of the composition, preferably
from
IS about 15 to about 75% by weight, and most preferably from about 20 to about
40 % by weight. The amount of conventional additives typically ranges fmm
about 0 to about 20 % by weight, based on the total weight of the composition,
preferably from about 1 to about 15 % by weight, and most preferably from
about
4 to about 10 % by weight.
20 As an emulsion, the emulsified composition of the present invention
includes an oil phase and an aqueous phase. The oil phase preferably is
present
in an amount within the range of from about 1 to about 75 % by weight, based
on
the total weight of the composition, more preferably, from about 5 to about
60%
by weight, and most preferably from about 40 to about 60 % by weight.
25 Emulsifiers can be used to assist in preparing the emulsified cosmetic
makeup composition of the invention. Any cosmetically acceptable emulsifier
can
be used in an amount that provides the desired emulsifying effect. Preferably,
the
emulsifier is selected from known soaps and surfactants, more preferably, the
emulsifier is selected from stearic acid, sorbitan sesquioleate, polyethylene
glycol
30 (PEG)-30 dipolyhydroxystearate, lecithin, magnesium stearate, and
derivatives and
mixtures thereof. The emulsifiers preferably are used in an additive amount
within the range of from about 0.5 to about 30% by weight, based on the total
_I7_
CA 02314935 2000-06-15
WO 99/30681 PCTNS98/26580
weight of the composition, more preferably, from about 1 to about 12 % by
weight
and most preferably from about 4 to about 8 % by weight.
Those skilled in the art are capable of selecting particular ingredients for
_ use in the present composition, and they are capable of determining an
appropriate
amount of ingredient to provide a water in silicone emulsified cosmetic makeup
composition.
A particularly preferred composition for reducing the appearance of fine
lines and wrinkles, moisturizing and protecting the skin from the harmful
effects
of sunlight includes a water in silicone emulsion containing about 0.1 to 25
weight
% ultrafme titanium dioxide, from about 0.1 to 25 weight % of micmfme zinc
oxide, from about 0.1 to ZS weight % of a mixture of gluconolactone (as a
polyhydroxy acid) and glycolic acid (as an alpha hydroxyacid) neutralized to a
pH
of 3.80 with any base, preferably ammonium hydroxide, from about 0.1 to 5
weight % of vitamin E derivative, preferably vitamin E iinoleate, from about
0.1
to 5 weight % of a moisturizing agent, preferably glycerin and from about 0.1
to
% of a blend of cosmetically acceptable pigments, preferably polyfluoroalkyl
coated inorganic pigments.
Even more preferred embodiments of the invention include the use of
microfine titanium dioxide coated with aluminum hydroxide and stearic acid
20 (aluminum stearate), cosmetic grade titanium dioxide coated with C9-C15
polyfluoroalkyl phosphate, and polymer coated zinc oxide as sunscreen agents,
Gluconolactone and/or glycolic acid as the hydroxy acid(s), Vitamin E
linoleate
as a natural antioxidant, glycerin and/or butylene glycol as moisturizing
agent{s)
(i. e. , humectant(s)), and cosmetically acceptable iron oxide pigments.
25 To prepare an emulsified cosmetic composition in accordance with the
present invention, at least one hydroxy acid or related compound first is
dissolved
in a solution prepared from ethanol, water, propylene glycol, butylene glycol,
acetone or other pharmaceutically acceptable vehicle, and then neutralized
with an
appropriate base. The emulsified cosmetic composition can be prepared as
follows:
A) dissolving in water at least one hydroxy acid selected from
polyhydroxy acid, alpha hydroxy acid, beta hydroxy acid, keto carboxylic acid
-18-
CA 02314935 2000-06-15
WO 99/30681 PCTNS98/26580
and related compounds in water and neutralizing with an appropriate base to a
pH
of above 3.0 to provide phase A;
B) providing an aqueous mixture containing at least one moisturizing
- agent, heating the mixture, and adding this mixture to phase A to provide
phase
S AB;
C) mixing at least one sunscreen agent, at least one antioxidant, at least
one emulsiFer and at least one silicone-containing compound at room
temperature,
followed by heating and homogenizing the mixture to provide phase C;
D) providing a mixture containing at least one sunscreen agent and at
least one cosmetically acceptable pigment, homogenizing the mixture to provide
p~ D;
E) mixing phases C) and D) together and homogenize until uniform to
provide mixture CD;
F) slowly adding phase AB to phase CD to produce phase F;
G) adding to phase F a mixture containing parabens; and
H) adding additional cosmetically acceptable pigments to provide the
appropriate color.
In step A), the hydroxyacid preferably is gluconolactone and/or glycolic
acid. In step B), the moisturizing agents) preferably are 1,3-butylene glycol
and
glycerine and the mixture is heated to a temperature within the range of from
about 35-50°C, preferably from about 40-45°C. The mixture of
step B)
preferably is stirred for about 10 minutes prior to addition to phase A). It
is
preferred to mix the ingredients of phase C) together at room temperature,
whereby the pigment preferably is titanium dioxide, the emulsifier preferably
is
sorbitan sesquioleate and lecithin, the antioxidant preferably is Vitamin E
linoleate
and the silicone-containing compound preferably is selected from
cyclomethicone
and dimethicone. The components of phase C) preferably are mixed together at
room temperature, followed by heating and homogenizing for about 30 minutes or
until the mixture is substantially homogeneous.
In preparing the emulsified cosmetic composition of the invention, it is
preferred to use only a portion of the cosmetically acceptable pigment to
prepare
phase D), more preferably, use only 90 % of the pigment, most preferably 80 %
.
The remaining pigment may be added later in step H) to adjust the color of the
-19-
CA 02314935 2000-06-15
- WO 99/30681 PCT/US98/265$0
cosmetic composition. The mixture of phase D) preferably is homogenized for
about 30 minutes until uniform. Phase D) then is added to phase C) and the
mixture of CD) is homogenized for about 30 minutes until uniform. In step F),
phase AB) is slowly added to phase CD) with slow speed mixing. A mixture
containing parabens then is added to the mixture of AB) and CD) with high
mixing and mixed for at least 5 minutes, and the color of the final emulsion
is
adjusted using the remaining pigment from step D).
The present invention also encompasses a method of reducing the
appearance of fine lines and wrinkles, protecting the skin from ultraviolet
radiation exposure, moisturizing and soothing the skin comprising topically
applying a water in silicone emulsified cosmetic makeup composition of the
invention to an area of the skin in need thereof. Preferably, the composition
is
applied to areas of the skin that are typically exposed to ultraviolet
radiation, such
as the arms, hands, face, feet, legs, chest, buttocks and abdomen, although
the
composition of the invention can be applied to any area of skin. The
composition
of the present invention preferably is applied on a daily basis, and more
preferably, twice daily in order to achieve the appropriate effects.
Preferably, the
composition of the present invention is applied twice daily for a period of at
least
2 months, preferably at least 5 months, and most preferably more than 8 months
to achieve a reduction in the appearance of fine lines and wrinkles. The rate
and
duration of application can be varied, however, depending on the concentration
of
effective ingredients. Skilled artisans are capable of designing a suitable
application regimen to provide the requisite fine line and wrinkle reducing
effect
as well as ultraviolet exposure reducing effect using the guidelines provided
herein.
The following are illustrative examples of formulations and compositions
according to this invention. Although the examples utilize only selected
compounds and formulations, it should be understood that the following
examples
are illustrative and not limited. Therefore, any of the known alpha
hydroxyacids,
polyhydroxy acids, beta hydroxyacids, keto carboxylic acids, related
compounds,
moisturizing agents, antioxidants, silicone-containing compounds, emulsifiers,
pigments and sunscreen agents may be substituted according to the teachings of
this invention in the following examples.
-20-
CA 02314935 2000-06-15
WO 99/30681 PCTNS98/26580
EXAMPLES
A preferred makeup composition and its method of manufacture is
described below.
PHASE INGREDIENTS
A DI WATER 20.900
GLUCONOLACTONE 4,000
AMMONIUM HYDROXIDE 0,600
SODIUM CHLORIDE 1.000
.
B 1,3-BUTYLENE GLYCOL 3,ppp
PEG-30 DIPOLYHYDROXYSTEARATE 1.000
N-ETHYL N-SOYAMORPHOLIrIIUM 1.000
ETHOSULFATE/WATER
GLYCERINE 2,000
C TITANIUM DIOXIDE/ISOSTEARYL 10.000
NEOPENTANOATE/
STEARIC ACID/ALUMINUM
HYDROXIDE
POLYMETHYL METHACRYLATE 2.000
CYCLOMETHICONE/DIMETHICONE 5.000
COPOLYOL
NYLON-12 2.500
ISODODECANE 3.500
ISOHEXADECANE 3,000
VTTAMIN E LINOLEATE 0.500
SORBITAN SESQUIOLEATE 1.000
CETYL DIMETHICONE COPOLYOL 1.500
CYCLOMETHICONE/QUATERNIUM-18 5.000
HECTORITE/
PROPYLENE CARBONATE
LECITHIN 0.500
MAGNESIUM STEARATE 0.500
POLYETHYLENE 2.000
SILICA 1.500
SILK POWDER 1,000
D TITANIUM DIOXIDE 3.000
CYCLOMETHICONE 15.000
TALC 0.500
IRON OXIDE YELLOW 5.330
IRON OXIDE RED 1.420
IRON OXIDE BLACK 0.750
E PHENOXYETHANOL/ISOPROPYL 1.000
PARABEN/
ISOBUTYL PARABEN/BUTYL PARABEN
100.00
-2I-
CA 02314935 2000-06-15
WO 99/30681 PCTNS98/265$0
The above cream makeup composition was prepared as follows, whereby the
amounts of ingredients are indicated above in weight percent.
1) Gluconolactone was dissolved in water, stirred for about 3 hours,
- and the pH was adjusted_to 3.80 with addition of ammonium hydroxide. Sodium
chloride then was added to the solution to prepare phase A.
2) The ingredients for phase B then were mixed together and heated
to 40-45°C. The heated mixture was stirred for about 10 minutes and
added to
phase A above to provide phase AB.
3) The ingredients of phase C were mixed together in a separate
container at room temperature, followed by heating and homogenizing for 30
minutes until uniform to provide phase C.
4) In a container separate from that used to prepare phase C), and
using only 80 % of the iron oxide pigment, the ingredients of phase D (less
the
20% of iron oxide pigment) were mixed together and homogenized for 30 minutes
until uniform to provide phase D.
5) Phase D then was added to phase C to prepare phase CD), and
phase CD) was homogenized for 30 minutes until uniform.
6) The ingredients of phase AB then were slowly added to phase CD
with slow speed mixing.
'7) The ingredients of phase E then were added to the emulsion of step
6), and the emulsion was homomixed at high speed for 5 minutes. The color of
the resulting emulsified cosmetic composition was adjusted and matched using
the
remaining 20% of iron oxide pigments from step 4) to prepare a water in
silicone
emulsified cosmetic makeup composition.
The water in silicone emulsified cosmetic makeup composition then can be
applied to various places on the body, preferably on the face, arms and hands,
and
used as both an effective sunscreen and as a composition effective in removing
or
alleviating the signs of aging such as fme lines and wrinkles.
It will be apparent to those skilled in the art that various modifications and
variations can be made to the compositions of matter and methods of this
invention. Thus, it is intended that the present invention covers such
modifications and variations.
-22-
